Simplex Trading, LLC Immuno Precise Antibodies Ltd. Call Options Transaction History
Simplex Trading, LLC
- $175 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding IPA
# of Institutions
22Shares Held
1.12MCall Options Held
77.9KPut Options Held
0-
Susquehanna International Group, LLP Bala Cynwyd, PA699KShares$1.19 Million0.0% of portfolio
-
Xtx Topco LTD London, X091.4KShares$155,3490.0% of portfolio
-
Two Sigma Investments, LP New York, NY90.9KShares$154,4530.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny40.5KShares$68,8160.0% of portfolio
-
Virtu Financial LLC New York, NY28.9KShares$49,1700.0% of portfolio
About ImmunoPrecise Antibodies Ltd.
- Ticker IPA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,836,700
- Market Cap $42.2M
- Description
- ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...